Top Industry Leaders in the Hydroxychloroquine Market
Latest Hydroxychloroquine Companies Update:
Novartis and Teva Pharmaceuticals remain focused on improving Hydroxychloroquine for treating these autoimmune diseases. Research exploring new formulations and delivery methods to enhance efficacy and minimize side effects is ongoing.
In March 2023, Novartis announced a renewed commitment to donating up to 130 million doses of Hydroxychloroquine to support global efforts in treating lupus and malaria.
In November 2023, Indian pharmaceutical company Lupin launched a new formulation of Hydroxychloroquine with improved absorption and reduced side effects for patients with lupus.
List of Hydroxychloroquine Key companies in the market
- 
Sanofi S.A.
 - 
Teva Pharmaceutical Industries Ltd.
 - 
Zydus Cadila
 - 
Mylan N.V.
 - 
Novartis International AG
 - 
Hikma Pharmaceuticals
 - 
Ipca Laboratories
 - 
Apotex Corporation
 - 
Cipla
 - 
Wallace Pharmaceuticals
 - 
Covis Pharmaceuticals Ltd.
 - 
Lupin Pharmaceutical
 - 
McW Healthcare
 - 
Intas Pharmaceuticals
 - 
Macleods Pharmaceuticals
 - 
Hanlim Pharmaceutical
 - 
Concordia Healthcare
 - 
Taj Pharmaceuticals
 - 
Laurus Labs Limited
 - 
Shanghai Pharmaceuticals Holding
 - 
Kyung Poong